Neopharmed Gentili Competitors and Similar CompaniesClear all
Aravive's competitors and similar companies include Angion Biomedica, Verrica Pharmaceuticals and Opsis Therapeutics.
 Aravive Aravive is a clinical-stage biotechnology company developing therapies for solid tumors and hematologic malignancies. |  Angion Biomedica Angion Biomedica Corp is a biopharmaceutical company focused on acute kidney injury, acute lung injury, and CNS injury. |  Verrica Pharmaceuticals Verrica Pharmaceuticals is developing proprietary topical therapies for the treatment of lesional skin diseases such as Verruca vulgaris (common warts and plantar warts) and Molluscum contagiosum. |  Opsis Therapeutics Opsis Therapeutics is a biotechnology company engaged in the development of treatments for retinal diseases. | |
Founding Date | Founding Date 2008 | Founding Date 1998 | Founding Date 2013 | Founding Date 2016 |
Type | Type Public | Type Private | Type Public | Type Private |
Tags | ||||
Locations | Locations Houston, US HQ | Locations San Francisco, US HQ Uniondale, US | Locations West Chester, US HQ | Locations HQ |
Employees | Employees 23 | Employees 205% increase | Employees 176% increase | Employees 5 |
Valuation ($) | Valuation ($) 2.9 m | Valuation ($) N/A | Valuation ($) 71.7 m | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) $9.1m (FY, 2022) | Revenue (est.) $2.3m (FY, 2022) | Revenue (est.) $35.6m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income ($76.3m) (FY, 2022) | Net income ($38.8m) (FY, 2022) | Net income ($17.9m) (FY, 2025) | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
Angion Biomedica
HQ
San Francisco, US
Employees
20↑ 5% increase
Angion Biomedica Corp is a biopharmaceutical company focused on acute kidney injury, acute lung injury, and CNS injury.
View companyVerrica Pharmaceuticals
HQ
West Chester, US
Employees
17↑ 6% increase
Verrica Pharmaceuticals is developing proprietary topical therapies for the treatment of lesional skin diseases such as Verruca vulgaris (common warts and plantar warts) and Molluscum contagiosum.
View companyOpsis Therapeutics
HQ
Employees
5
Opsis Therapeutics is a biotechnology company engaged in the development of treatments for retinal diseases.
View company